For each of the following patients presenting with clinical and biochemical evidence of hepatic injury, select the most appropriate confirmatory or highly specific diagnostic laboratory evaluation.
- A 34-year-old man presents with progressive resting tremor, dysarthria, and behavioral changes. Hepatic panel reveals an aspartate aminotransferase of 85 U/L and an alanine aminotransferase of 92 U/L.Serum ceruloplasmin level and 24-hour urinary copper excretion
- A 51-year-old woman describes three months of debilitating fatigue and severe generalized pruritus. Her alkaline phosphatase is 410 U/L with normal transaminases. Abdominal ultrasound shows no biliary dilation.Antimitochondrial antibody (AMA) titer
- A 29-year-old primigravida at 34 weeks gestation develops intense nighttime itching predominantly on her palms and soles. Laboratory testing shows mildly elevated transaminases with a normal gamma-glutamyl transferase.Fasting serum total bile acid concentration
- A 45-year-old man with type 2 diabetes mellitus presents with new-onset symmetric arthralgias in his second and third metacarpophalangeal joints. Hepatic panel reveals an alanine aminotransferase of 115 U/L.Serum transferrin saturation and ferritin levels
- A 38-year-old woman with a history of hypothyroidism presents with acute-onset jaundice and fatigue. Laboratory evaluation shows an aspartate aminotransferase of 580 U/L, alanine aminotransferase of 640 U/L, and hypergammaglobulinemia.Anti-smooth muscle antibody and anti-liver/kidney microsomal type 1 antibody assays
Answer
Each patient's unique demographic profile, symptom cluster, and initial hepatic panel pattern dictates a highly specific targeted laboratory evaluation: copper studies for Wilson disease, AMA for primary biliary cholangitis, bile acids for intrahepatic cholestasis of pregnancy, iron studies for hemochromatosis, and ASMA/anti-LKM1 for autoimmune hepatitis.
Each clinical scenario provides cardinal demographic features, extrahepatic manifestations, and initial biochemical patterns (hepatocellular vs. cholestatic) that narrow the differential diagnosis to a single leading etiology. Selecting the precise targeted laboratory test prevents unnecessary invasive procedures, limits diagnostic cost, and expedites definitive management.
Step-by-Step Solution
Key Concept
Targeted Diagnostic Laboratory Sequencing for Hepatic Pathology
Estimated Time:2m 0s